Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Cash from Investing Activities (2019 - 2024)

InMed Pharmaceuticals has reported Cash from Investing Activities over the past 4 years, most recently at -$2.0 for Q1 2024.

  • For Q1 2024, Cash from Investing Activities rose 100.0% year-over-year to -$2.0; the TTM value through Jun 2024 reached -$161806.0, up 81.84%, while the annual FY2024 figure was -$9293.0, 98.6% up from the prior year.
  • Cash from Investing Activities for Q1 2024 was -$2.0 at InMed Pharmaceuticals, up from -$33606.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $306011.0 in Q4 2021 and troughed at -$725457.0 in Q2 2022.
  • A 4-year average of -$119257.9 and a median of -$33606.0 in 2023 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: crashed 3508.16% in 2023 and later surged 100.0% in 2024.
  • Year by year, Cash from Investing Activities stood at $306011.0 in 2021, then tumbled by 337.07% to -$725457.0 in 2022, then skyrocketed by 95.37% to -$33606.0 in 2023, then skyrocketed by 99.99% to -$2.0 in 2024.
  • Business Quant data shows Cash from Investing Activities for INM at -$2.0 in Q1 2024, -$33606.0 in Q2 2023, and -$128198.0 in Q1 2023.